CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C16104 | BRD-K43149758 | myricetin | PIK3CG | Androgen receptor agonist; Cytochrome P450 inhibitor | -- | Details |
| C16105 | BRD-K43151809 | BRD-K43151809 | -- | -- | -- | Details |
| C16106 | BRD-K43159427 | BRD-K43159427 | -- | -- | -- | Details |
| C16107 | BRD-K43160803 | BRD-K43160803 | -- | -- | -- | Details |
| C16108 | BRD-K43162151 | BRD-K43162151 | -- | -- | -- | Details |
| C16109 | BRD-K43164539 | cholic-acid | CES1; FECH; PLA2G1B | Bile acid | -- | Details |
| C16110 | BRD-K43164817 | BRD-K43164817 | -- | -- | -- | Details |
| C16111 | BRD-K43168251 | BRD-K43168251 | -- | -- | -- | Details |
| C16112 | BRD-K43170571 | BRD-K43170571 | -- | -- | -- | Details |
| C16113 | BRD-K43177857 | BRD-K43177857 | -- | -- | -- | Details |
| C16114 | BRD-K43179840 | BRD-K43179840 | -- | -- | -- | Details |
| C16115 | BRD-K43184721 | BRD-K43184721 | -- | -- | -- | Details |
| C16116 | BRD-K43186783 | BRD-K43186783 | -- | -- | -- | Details |
| C16117 | BRD-K43187018 | GDC-0349 | PIK3CA | Pim kinase inhibitor | -- | Details |
| C16118 | BRD-K43187427 | BRD-K43187427 | -- | -- | -- | Details |
| C16119 | BRD-K43188042 | BRD-K43188042 | -- | -- | -- | Details |
| C16120 | BRD-K43192646 | BRD-K43192646 | -- | -- | -- | Details |
| C16121 | BRD-K43192836 | BRD-K43192836 | -- | -- | -- | Details |
| C16122 | BRD-K43194109 | BRD-K43194109 | -- | -- | -- | Details |
| C16123 | BRD-K43194164 | BRD-K43194164 | -- | -- | -- | Details |
| C16124 | BRD-K43203897 | BRD-K43203897 | -- | -- | -- | Details |
| C16125 | BRD-K43205312 | BRD-K43205312 | -- | -- | -- | Details |
| C16126 | BRD-K43206373 | BRD-K43206373 | -- | -- | -- | Details |
| C16127 | BRD-K43206993 | BRD-K43206993 | -- | -- | -- | Details |
| C16128 | BRD-K43209476 | BRD-K43209476 | -- | -- | -- | Details |
| C16129 | BRD-K43212439 | BRD-K43212439 | -- | -- | -- | Details |
| C16130 | BRD-K43216840 | BRD-K43216840 | -- | -- | -- | Details |
| C16131 | BRD-K43218507 | BRD-K43218507 | -- | -- | -- | Details |
| C16132 | BRD-K43224838 | BRD-K43224838 | -- | -- | -- | Details |
| C16133 | BRD-K43225681 | BRD-K43225681 | -- | -- | -- | Details |
| C16134 | BRD-K43226598 | BRD-K43226598 | -- | -- | -- | Details |
| C16135 | BRD-K43230258 | AN-2728 | -- | -- | crisaborole | Details |
| C16136 | BRD-K43231198 | BRD-K43231198 | -- | -- | -- | Details |
| C16137 | BRD-K43234208 | BRD-K43234208 | -- | -- | -- | Details |
| C16138 | BRD-K43234716 | CTPB | -- | -- | ctpb | Details |
| C16139 | BRD-K43236057 | polydatin | ICAM1 | ICAM-1 expression inhibitor | -- | Details |
| C16140 | BRD-K43237307 | BRD-K43237307 | -- | -- | -- | Details |
| C16141 | BRD-K43240808 | BRD-K43240808 | -- | -- | -- | Details |
| C16142 | BRD-K43245338 | MDL-28170 | CTSB; CAPN1 | Calpain inhibitor | -- | Details |
| C16143 | BRD-K43248184 | BRD-K43248184 | -- | -- | -- | Details |
| C16144 | BRD-K43249401 | BRD-K43249401 | -- | -- | -- | Details |
| C16145 | BRD-K43253317 | BRD-K43253317 | -- | -- | -- | Details |
| C16146 | BRD-K43256821 | BRD-K43256821 | -- | -- | -- | Details |
| C16147 | BRD-K43261169 | BRD-K43261169 | -- | -- | -- | Details |
| C16148 | BRD-K43263266 | BRD-K43263266 | -- | -- | -- | Details |
| C16149 | BRD-K43266948 | BRD-K43266948 | -- | -- | -- | Details |
| C16150 | BRD-K43267173 | BRD-K43267173 | -- | -- | -- | Details |
| C16151 | BRD-K43271856 | BRD-K43271856 | -- | -- | -- | Details |
| C16152 | BRD-K43279914 | BRD-K43279914 | -- | -- | -- | Details |
| C16153 | BRD-K43282617 | BRD-K43282617 | -- | -- | -- | Details |
| C16154 | BRD-K43283261 | SA-101841 | -- | -- | -- | Details |
| C16155 | BRD-K43283393 | BRD-K43283393 | -- | -- | -- | Details |
| C16156 | BRD-K43284834 | BRD-K43284834 | -- | -- | -- | Details |
| C16157 | BRD-K43286821 | BRD-K43286821 | -- | -- | -- | Details |
| C16158 | BRD-K43287163 | BRD-K43287163 | -- | -- | -- | Details |
| C16159 | BRD-K43289649 | BRD-K43289649 | -- | -- | -- | Details |
| C16160 | BRD-K43290182 | Ro-04-6790 | HTR6 | Serotonin receptor antagonist | -- | Details |
| C16161 | BRD-K43292469 | BRD-K43292469 | -- | -- | -- | Details |
| C16162 | BRD-K43295075 | BRD-K43295075 | -- | -- | -- | Details |
| C16163 | BRD-K43298189 | BRD-K43298189 | -- | -- | -- | Details |
| C16164 | BRD-K43298786 | BRD-K43298786 | -- | -- | -- | Details |
| C16165 | BRD-K43303828 | BRD-K43303828 | -- | -- | -- | Details |
| C16166 | BRD-K43305603 | rocuronium | CHRNA2 | Acetylcholine receptor antagonist | rocuronium-bromide | Details |
| C16167 | BRD-K43306617 | BRD-K43306617 | -- | -- | -- | Details |
| C16168 | BRD-K43316594 | BRD-K43316594 | -- | -- | -- | Details |
| C16169 | BRD-K43324262 | BRD-K43324262 | -- | -- | -- | Details |
| C16170 | BRD-K43325273 | BRD-K43325273 | -- | -- | -- | Details |
| C16171 | BRD-K43326597 | BRD-K43326597 | -- | -- | -- | Details |
| C16172 | BRD-K43327166 | BRD-K43327166 | -- | -- | -- | Details |
| C16173 | BRD-K43330982 | JTE-013 | S1PR2 | Lysophospholipid receptor antagonist | -- | Details |
| C16174 | BRD-K43336921 | BRD-K43336921 | -- | -- | -- | Details |
| C16175 | BRD-K43337737 | BRD-K43337737 | -- | -- | -- | Details |
| C16176 | BRD-K43341506 | BRD-K43341506 | -- | -- | -- | Details |
| C16177 | BRD-K43341819 | BRD-K43341819 | -- | -- | -- | Details |
| C16178 | BRD-K43345858 | BRD-K43345858 | -- | -- | -- | Details |
| C16179 | BRD-K43349162 | BRD-K43349162 | -- | -- | -- | Details |
| C16180 | BRD-K43349989 | BRD-K43349989 | -- | -- | -- | Details |
| C16181 | BRD-K43352598 | BRD-K43352598 | -- | -- | -- | Details |
| C16182 | BRD-K43357457 | ORG-25935 | -- | -- | -- | Details |
| C16183 | BRD-K43357772 | BRD-K43357772 | -- | -- | -- | Details |
| C16184 | BRD-K43359161 | BRD-K43359161 | -- | -- | -- | Details |
| C16185 | BRD-K43364707 | BRD-K43364707 | -- | -- | -- | Details |
| C16186 | BRD-K43368091 | ethyl-methanesulfonate | -- | -- | -- | Details |
| C16187 | BRD-K43374517 | BRD-K43374517 | -- | -- | -- | Details |
| C16188 | BRD-K43375231 | BRD-K43375231 | -- | -- | -- | Details |
| C16189 | BRD-K43379283 | BRD-K43379283 | -- | -- | -- | Details |
| C16190 | BRD-K43381631 | BRD-K43381631 | -- | -- | -- | Details |
| C16191 | BRD-K43384508 | BRD-K43384508 | -- | -- | -- | Details |
| C16192 | BRD-K43387144 | BRD-K43387144 | -- | -- | -- | Details |
| C16193 | BRD-K43388152 | BRD-K43388152 | -- | -- | -- | Details |
| C16194 | BRD-K43389675 | daunorubicin | TOP2A | RNA synthesis inhibitor; Topoisomerase inhibitor | -- | Details |
| C16195 | BRD-K43389698 | BMS-387032 | CDK2; CDK7; CDK9 | CDK inhibitor; MCL1 inhibitor; Cell cycle inhibitor | -- | Details |
| C16196 | BRD-K43390080 | BRD-K43390080 | -- | -- | -- | Details |
| C16197 | BRD-K43390655 | BRD-K43390655 | -- | -- | -- | Details |
| C16198 | BRD-K43396185 | BRD-K43396185 | -- | -- | -- | Details |
| C16199 | BRD-K43405658 | BRD-K43405658 | -- | -- | tyrphostin-AG-527 | Details |
| C16200 | BRD-K43407019 | SA-1456220 | -- | -- | -- | Details |
| C16201 | BRD-K43407975 | BRD-K43407975 | -- | -- | -- | Details |
| C16202 | BRD-K43410529 | MLN-2480 | -- | -- | -- | Details |
| C16203 | BRD-K43411248 | BRD-K43411248 | -- | -- | -- | Details |